US Patent 11759527 Anti-EGFR antibody-drug conjugates
Patent 11759527 was granted and assigned to AbbVie Inc. on September, 2023 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 11759527 Anti-EGFR antibody-drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
